IT1240612B - Procedimento di purificazione del b-interferone umano ricombinante - Google Patents

Procedimento di purificazione del b-interferone umano ricombinante

Info

Publication number
IT1240612B
IT1240612B IT19699A IT1969990A IT1240612B IT 1240612 B IT1240612 B IT 1240612B IT 19699 A IT19699 A IT 19699A IT 1969990 A IT1969990 A IT 1969990A IT 1240612 B IT1240612 B IT 1240612B
Authority
IT
Italy
Prior art keywords
recombinant human
interferon
human beta
eluted
beta
Prior art date
Application number
IT19699A
Other languages
English (en)
Other versions
IT9019699A1 (it
IT9019699A0 (it
Inventor
Otello Protasi
Paolo Rappuoli
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa filed Critical Sclavo Spa
Priority to IT19699A priority Critical patent/IT1240612B/it
Publication of IT9019699A0 publication Critical patent/IT9019699A0/it
Priority to DE69116582T priority patent/DE69116582D1/de
Priority to EP91103719A priority patent/EP0446850B1/en
Priority to AT91103719T priority patent/ATE133421T1/de
Priority to JP3074344A priority patent/JPH0568583A/ja
Priority to KR1019910004187A priority patent/KR910016928A/ko
Publication of IT9019699A1 publication Critical patent/IT9019699A1/it
Application granted granted Critical
Publication of IT1240612B publication Critical patent/IT1240612B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT19699A 1990-03-16 1990-03-16 Procedimento di purificazione del b-interferone umano ricombinante IT1240612B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT19699A IT1240612B (it) 1990-03-16 1990-03-16 Procedimento di purificazione del b-interferone umano ricombinante
DE69116582T DE69116582D1 (de) 1990-03-16 1991-03-12 Verfahren zur Herstellung von rekombinantem Humaninterferon-beta in reiner Form
EP91103719A EP0446850B1 (en) 1990-03-16 1991-03-12 Process for purifying recombinant human beta-interferon
AT91103719T ATE133421T1 (de) 1990-03-16 1991-03-12 Verfahren zur herstellung von rekombinantem humaninterferon-beta in reiner form
JP3074344A JPH0568583A (ja) 1990-03-16 1991-03-15 組換えヒトβ−インターフエロンの精製方法
KR1019910004187A KR910016928A (ko) 1990-03-16 1991-03-16 재조합 사람 β-인터페론의 정제방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19699A IT1240612B (it) 1990-03-16 1990-03-16 Procedimento di purificazione del b-interferone umano ricombinante

Publications (3)

Publication Number Publication Date
IT9019699A0 IT9019699A0 (it) 1990-03-16
IT9019699A1 IT9019699A1 (it) 1991-09-16
IT1240612B true IT1240612B (it) 1993-12-17

Family

ID=11160484

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19699A IT1240612B (it) 1990-03-16 1990-03-16 Procedimento di purificazione del b-interferone umano ricombinante

Country Status (6)

Country Link
EP (1) EP0446850B1 (it)
JP (1) JPH0568583A (it)
KR (1) KR910016928A (it)
AT (1) ATE133421T1 (it)
DE (1) DE69116582D1 (it)
IT (1) IT1240612B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551535A1 (en) * 1992-01-13 1993-07-21 SCLAVO S.p.A. Process for the purification of recombinant human beta interferon, beta interferon thus purified, and pharmaceutical compositions which contain them
KR100524872B1 (ko) 2003-12-04 2005-11-01 씨제이 주식회사 인터페론 베타의 정제방법
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity
IT1222427B (it) * 1987-07-31 1990-09-05 Sclavo Spa Procedimento per la purificazione di interferone

Also Published As

Publication number Publication date
ATE133421T1 (de) 1996-02-15
EP0446850B1 (en) 1996-01-24
DE69116582D1 (de) 1996-03-07
EP0446850A2 (en) 1991-09-18
EP0446850A3 (en) 1991-11-06
KR910016928A (ko) 1991-11-05
IT9019699A1 (it) 1991-09-16
IT9019699A0 (it) 1990-03-16
JPH0568583A (ja) 1993-03-23

Similar Documents

Publication Publication Date Title
DK0447585T3 (da) Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
PT813541E (pt) Processo de producao de uma proteina
CZ506785A3 (en) Human tumorous necrotic factor, process of its production, dna encoding the human tumorous necrotic factor, a cell transformed by this dna, agent in which the human tumorous necrotic factor is comprised and agent suitable to treating tumors
BR1100358A (pt) Processo para obter preparação purificada de um anticorpo igg preparada usando um sistema de expressão recombinante, preparação purificada em um anticorpo igg, uso da mesma e formulação
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
ES2146600T3 (es) Condroitinasa, procedimiento para su preparacion y composicion farmaceutica.
ATE4116T1 (de) Reinigung von menschlichem wachstumshormon.
ATE50794T1 (de) Verfahren zur reinigung einer physiologisch aktiven substanz, die durch rekombinante dnatechnik hergestellt wurde.
ES8407499A1 (es) Un metodo para la obtencion de interferon inmune humano homogeneo de pureza aumentada.
SE8005498L (sv) Homogent fibroblastinterferon och framstellning derav
IT1240612B (it) Procedimento di purificazione del b-interferone umano ricombinante
EP0188262A3 (en) Process for the isolation of chicken egg white cystatine, antiviral agents containing it and its use as viral protease inhibitor
NO895055L (no) Fremgangsmaate for fremstilling av endothelial cellevekstfaktor.
GB1401737A (en) Anti-coagulant isolation
HUP9901029A2 (hu) Eljárás rDSPA alfa1 előállítására
ATE136552T1 (de) Reinigung von menschlichem, aus einer escherichia coli mutante abgesonderten interleukin 4
DK0547031T3 (da) N-beskyttede (S)-isoserinforbindelser
ES2068392T3 (es) Procedimiento de purificacion de interferon.
FR1431697A (fr) Procédé de préparation de nouveaux acides aminés, entre autres l'acide gamma-amino-beta-(p-chlorophényl)butyrique
DK547486A (da) Peptider samt praeparater indeholdende disse
JPS54138189A (en) Separation and purification of urokinase
SE7500629L (it)
GB1024061A (en) Process for the purification of streptokinase
FR2107801A2 (en) Porous, cross-linked, biologically active product - for therapeutic or industrial uses

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940330